Connie D McDaniel bought $6,460 of NIE
director at Virtus Equity & Convertible Income Fund. 245 shares at an average of $26.37, traded Aug 20, 2026, filed Aug 24, 2026.
Score components
- +15RoleDirector
- 0Trade size$6k at market
- +10Relative to holdingsHoldings up 108%
- 0Price contextNear the top of the 52-week range
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- +5Track recordMedian 6-month excess return +3% over 6 past buys
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001101225-26-000008, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | POpen-market purchase Common Stock | +245 | $26.37 | $6,460 | 471 | Aug 24, 2026 |
Related signals
Other insiders at Virtus Equity & Convertible Income Fund and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | NIEsell Virtus Equity & Convertible Income Fund | Michael Yee other | $122k 4,605 shares | -100% | |
| 23Weak | NIEbuy Virtus Equity & Convertible Income Fund | Connie D McDaniel director | $5,191 226 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.